A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence

Inclusion Criteria:

- Symptoms of Overactive Bladder (OAB) (frequency/urgency) with urinary incontinence
for at least 6 months

- Inadequate response or limiting side effects with anticholinergics for the treatment
of OAB

Exclusion Criteria:

- Overactive Bladder caused by neurological condition

- Patient has predominance of stress incontinence

- Use of anticholinergics or other medications to treat OAB symptoms in the 7 days
prior to screening

- Previous use of solifenacin

- History or evidence of pelvic or urological abnormality

- Previous use of any botulinum toxin of any serotype for any urological condition

- Previous use of any botulinum toxin of any serotype for any non-urological condition
within 12 weeks of randomization

- Diagnosis of Myasthenia gravis, Eaton-Lambert Syndrome, Amyotrophic Lateral Sclerosis